Invention Grant
- Patent Title: Anti-OX40 antibodies and their uses
-
Application No.: US15843281Application Date: 2017-12-15
-
Publication No.: US10556962B2Publication Date: 2020-02-11
- Inventor: Fiona A. Harding
- Applicant: AbbVie Biotherapeutics Inc.
- Applicant Address: US CA Redwood City
- Assignee: AbbVie Biotherapeutics Inc.
- Current Assignee: AbbVie Biotherapeutics Inc.
- Current Assignee Address: US CA Redwood City
- Agency: Dechert LLP
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C07H21/04 ; C12P21/06 ; C12N15/87 ; C12N1/20 ; C12N15/74 ; C07K16/30 ; C07K16/28 ; A61P35/00 ; C12N15/85 ; A61K39/00
Abstract:
The present disclosure provides novel anti-OX40 antibodies, compositions including the antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.
Public/Granted literature
- US20180171023A1 ANTI-OX40 ANTIBODIES AND THEIR USES Public/Granted day:2018-06-21
Information query
